Diversity content roundup for National Minority Health Month
Every April is National Minority Health Month, organized by the U.S. Department of Health and Human Services. This month is intended to highlight the focus on improving the health of racial and ethnic minorities by reducing health disparities and increasing equal access to care.
The theme for this year is focused on the role that equitable healthcare services, information, and resources can play in improving health outcomes, as patients who are provided with information that is culturally and linguistically appropriate can be more empowered to make informed decisions about their health and treatment.
To celebrate this theme, Antidote wanted to share some of the information and resources that we provide surrounding diversity, equity, and inclusion (DEI) in clinical trials. The below resources range from interviews that discuss the frontlines of equitable research to case studies about how to improve diversity in clinical trials.
The importance of diversity in clinical trials [content roundup]
Interviews:
This Q&A with the National Minority Health Association (NMHA) focuses on the progress being made toward more inclusive research. The NMHA works to build relationships with its member base of over 70,000 individuals and provide them with a comprehensive path to health equity through resources, guidance, and information about clinical trials.
This powerful patient video shares the story of Shanelle Gabriel who details the realities of living with lupus and navigating the process of becoming empowered in her treatment decisions.
Talk of the Towne Episode 05: Diversity in research with Allison Kalloo
Antidote’s podcast episode featuring Allison Kalloo digs deep into the reasonings behind the lack of diversity in clinical trials and what everyone in the industry can do to move the needle towards lasting change.
Blogs:
Why racial diversity in clinical trials is so important
It’s understood that an accurate patient participant pool is important to quality research, but this blog goes further into detail about exactly how a lack of diversity can hurt the medical insights that clinical studies obtain.
Three key ways to drive diversity in clinical trials
There are multiple reasons why clinical trials are lacking in diversity, and as such, there are multiple ways that industry professionals can address the problem. However, in this blog, we share three of the most vital ways that researchers can make a difference.
How to move from diversity to inclusion in medical research
True equity in medical research is about more than hitting a number target — it is vital that sponsors, site staff, and all other industry professionals are taking an active role to be champions for true inclusion and equitable access for participants.
Collateral:
Antidote’s approach to driving diversity, equity, and inclusion in patient recruitment [whitepaper]
In this whitepaper, we discuss our own approach to driving DEI in clinical trial patient recruitment. From our outreach strategies to our ad designs, we are always thinking about how we can recruit the right people for the right studies.
Diversity, equity, and inclusion in clinical research [one-pager]
This one-pager details the current state of DEI in clinical research today to illustrate how we can create measurable improvement strategies for a more inclusive tomorrow.
Driving diversity in recruitment [case study]
This case study discusses our experience with recruiting for a Sickle Cell Disease (SCD) clinical trial. Because SCD is a condition that disproportionately impacts Black and African American populations, we were able to utilize our outreach expertise to target the right communities for this study.
In order to create true change within the medical research industry, it is important that people of all backgrounds are represented in clinical trials. If you would like to take part in a research study, getting started is easy — just use the button below.
